From: Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Mitochondria-targeting strategies | Description | Compositions | Characteristics | Refs. |
---|---|---|---|---|
Conventional chemotherapy | A promising strategy that directly acts on mitochondria to produce toxic substances to cells and induces cancer cell death by endogenous chemical energy without the stimulation of external light sources | CT drugs (Betulinic Acid, Resveratrol, Ditercalinium Chloride, Benzo-α-pyrone (coumarin), α-TOS, Organic Arsenicals) | Easy to penetrate mitochondrial membrane and target mitochondria due to high lipid solubility; high effectiveness of tumor treatment | |
Nanoplatform loaded with CT/RT drugs | CT/RT drugs are modified by mitochondria-targeting units or designed as nanoplatforms for cancer treatment | CT/RT drugs (Lonidamine, Paclitaxel, Doxorubicin, Cisplatin); mitochondria-targeting units | High effectiveness of tumor treatment | |
CDT | A burgeoning therapy through undergoing a fenton reaction or a fenton-like reaction, which reacts with excessive intracellular hydrogen peroxide (H2O2) in tumor tissues to generate hydroxyl radicals (·OH) | CT drugs; mitochondria-targeting units | Low invasiveness; consumption of endogenous H2O2 without external energy; little normal tissue toxicity | |
PTT | Killing cancer cells with thermal damage (conversion of light energy into heat) utilizing an external light source (usually near-infrared (NIR) light) and photothermal agent as heat-generating source; PTT has strong absorption characteristics for NIR | Photothermal materials, external light source; mitochondria-targeting unit | Deep penetration and minimal damage to surrounding healthy tissue; noninvasiveness; Minimal side effects; temporal and spatial selectivity | |
PDT | A locally targeted therapy utilizing a photosensitizer (PS), light, and oxygen to selectively kill tumors | PS, light, oxygen, serval lipophilic, and cationic groups | Accurate controllability; minimal drug resistance | |
RT-RDT | Stimulating PS to produce 1O2 to kill tumors under ionizing radiation | PS, 1O2, and mitochondria-targeting unit | Reach deeper tissues; low dosage possessing effective therapeutic effect | |
SDT | To kill cancer cells by stimulating exogenous (ultrasound) to activate SDT agents for producing ROS, cavitation, air bubbles, and hyperthermia | Ultrasound, SDT agents, ROS, cavitation, air bubbles, and hyperthermia | Depth of tumor tissues can be realized by ultrasound; Achievement of noninvasive treatment; high precision of target lesion zones | [611] |
Gene therapy | Replacement of defective genes by delivering wild-type ones into the host cell, or silencing a dominant mutant allele that is pathogenic to address mitochondrial diseases, | Therapeutic cargoes; delivery system | Precision treatment | |
Gas therapy | Using gaseous molecules to combat cancer | Gaseous molecules such as nitric oxide, CO, hydrogen sulfide, and hydrogen; mitochondria-targeting unit | Noninvasive in situ treatment with no depth limit | |
Combination therapy | Combination of CT and PTT, CT and CDT, PDT and PTT, PDT and CDT; PDT and CT; PDT and Immunotherapy | / | Achieve synergistic effect of anticancer; minimize multidrug resistance; reduced pain in patients |